Is it fair to drug companies to cut the price of insulin?

Starting in 2023, the Inflation Reduction Act will cap the cost of insulin for Medicare beneficiaries at $35 per month and will include those who use insulin pumps.

Cutting the price is unfair to big drug companies!
It's fair - drug companies are literally killing people with their pricing!
Select gender and age to cast your vote:
Is it fair to drug companies to cut the price of insulin?
Post Opinion